17-35986637-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032963.4(CCL14):c.13G>A(p.Val5Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL14 | NM_032963.4 | c.13G>A | p.Val5Met | missense_variant | 1/3 | ENST00000618404.5 | NP_116739.1 | |
CCL15-CCL14 | NR_027922.3 | n.1002G>A | non_coding_transcript_exon_variant | 5/7 | ||||
CCL14 | NM_032962.5 | c.13G>A | p.Val5Met | missense_variant | 1/4 | NP_116738.1 | ||
CCL15-CCL14 | NR_027921.3 | n.1002G>A | non_coding_transcript_exon_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL14 | ENST00000618404.5 | c.13G>A | p.Val5Met | missense_variant | 1/3 | 1 | NM_032963.4 | ENSP00000481023 | P1 | |
ENST00000612584.1 | n.245C>T | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 248844Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134704
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461616Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727120
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74298
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at